Newsroom

The Ivy Center proudly announces our participation in the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting for two Phase 0 clinical trials of infigratinib and niraparib in recurrent high-grade glioma and newly-diagnosed glioblastoma.

The Ivy Brain Tumor Center and Barrow Neurological Institute are pleased to announce the addition of Yoshie Umemura, MD, as the new Chief Medical Officer of the Ivy Brain Tumor Center and Division Chief of Neuro-Oncology and the William and Joan Shapiro Chair of Neuro-Oncology at Barrow Neurological Institute. 

As a neurosurgical resident at Barrow Neurological Institute, Charuta Furey is paving the way for women in her field. At the age of seven, Charuta’s mother was diagnosed with a glioma. Since that moment, Dr. Furey has committed her life to helping others who have been diagnosed with brain cancer. Check out ABC15's latest story in honor of Mother's Day.

The Ivy Brain Tumor Center is leading the way in brain cancer research and treatment. May is Brain Tumor Awareness Month and the Ivy Center has partnered with several major organizations across the state to bring much-needed attention to and support for Brain Tumor Awareness Month.

Phoenix Magazine featured the Ivy Brain Tumor Center's Dine and Donate event for the month of May. The event is a collaboration between the Barrow Neurological Foundation and Hensley Beverage Company to raise money for brain tumor research at the Ivy Brain Tumor Center. Local eateries that participate in the fundraiser will donate a portion of their sales throughout May, or feature a special menu item to support the cause.

Christi Endicott, a brave mother of two and brain tumor survivor was featured on AZ Family News sharing her brain tumor survival story. Christi is gearing up to take on the Boston Marathon and highlights her journey and how she persevered through the challenges of brain cancer.

Jenn Ortiz, a mother of two, is celebrating three years of survivorship this August! Her journey with brain cancer began at the Ivy Center when she was diagnosed with glioblastoma. Despite the challenges she's faced, Jenn remains optimistic, inspiring those around her with her perseverance and undeniable sense of humor. Jenn joined ABC15 Arizona to share her story.

In OncLive's latest article, they highlight the medical community's increasing interest in how high-grade meningiomas, a common type of brain tumor, might be treated with genomics. Dr. Nader Sanai, at the Ivy Brain Tumor Center, discusses the potential of Phase 0 clinical trials in better testing new treatments for this type of brain cancer.

Ivy Center Postdoctoral Fellow Costanza Lo Cascio, PhD, was featured in the latest issue of Oncology Fellows. The article highlights the importance of a pharmacokinetic and pharmacodynamic-guided approach in neuro-oncology preclinical trials to fast-track development of the most promising brain-penetrant drugs for glioblastoma treatment.

The Ivy Brain Tumor Center's Pharmacodynamics Core Leader An-Chi Tien has been awarded a one-year, $50,000 grant for work in genetic analysis of meningioma tumors by the American Brain Tumor Association.